As Pharma Releases Grip on Purse Strings, Waters LC-MS System Sales Rise 18 Percent | GenomeWeb
A rebound in spending by large pharmaceutical accounts combined with ongoing demand for instruments helped Waters this week post a 17-percent increase in second-quarter sales.
Overall revenue for the three months ended June 30 rose to $353 million from $302 million year over year, aided by an 18-percent jump in sales of instruments with proteomic uses. Profits rose to $59.9 million, up 25 percent from $47.8 million a year ago.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.